ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Extendicare Inc

Extendicare Inc (EXE)

7.54
0.06
(0.80%)
Closed June 16 4:12PM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
7.54
Bid
7.52
Ask
7.57
Volume
96,450
7.40 Day's Range 7.60
5.75 52 Week Range 8.03
Market Cap
Previous Close
7.48
Open
7.47
Last Trade
40
@
7.54
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
134,470
Shares Outstanding
11,778,000
Dividend Yield
-
PE Ratio
2.61
Earnings Per Share (EPS)
2.89
Revenue
1.3B
Net Profit
33.98M

About Extendicare Inc

Sector
Nursng,personal Care Fac,nec
Industry
Real Estate Investment Trust
Headquarters
Markham, Ontario, Can
Founded
1993
Extendicare Inc is listed in the Nursng,personal Care Fac sector of the Toronto Stock Exchange with ticker EXE. The last closing price for Extendicare was $7.48. Over the last year, Extendicare shares have traded in a share price range of $ 5.75 to $ 8.03.

Extendicare currently has 11,778,000 shares outstanding. The market capitalization of Extendicare is $88.57 million. Extendicare has a price to earnings ratio (PE ratio) of 2.61.

EXE Latest News

Extendicare Announces Voting Results for its 2024 Annual Meeting of Shareholders

MARKHAM, Ontario, May 23, 2024 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today announced the results of matters voted on at its annual meeting of...

Extendicare Announces 2024 First Quarter Results

MARKHAM, Ontario, May 15, 2024 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today reported results for the three months ended March 31, 2024. Results are...

Extendicare Announces April 2024 Dividend of C$0.04 per Share

MARKHAM, Ontario, April 15, 2024 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has declared a cash dividend of C$0.04 per common share of the...

Extendicare Announces Timing of 2024 First Quarter Results and Conference Call

MARKHAM, Ontario, April 04, 2024 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced today that it plans to release its financial results for the first...

Extendicare Announces 2023 Fourth Quarter and Year End Results

MARKHAM, Ontario, March 07, 2024 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today reported results for the three and twelve months ended December 31, 2023...

Extendicare ouvre les marchés

Extendicare ouvre les marchés Canada NewsWire TORONTO, le 15 févr. 2024 TORONTO, le 15 févr. 2024 /CNW/ - Le Dr Michael Guerriere, président et chef de la direction, Extendicare Inc. («...

Extendicare Opens the Market

Extendicare Opens the Market Canada NewsWire TORONTO, Feb. 15, 2024 TORONTO, Feb. 15, 2024 /CNW/ - Dr. Michael Guerriere, President and Chief Executive Officer, Extendicare Inc...

Extendicare Announces February 2024 Dividend of C$0.04 per Share

MARKHAM, Ontario, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has declared a cash dividend of C$0.04 per common share of the...

Extendicare Announces Timing of 2023 Fourth Quarter Results and Conference Call

MARKHAM, Ontario, Jan. 19, 2024 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced today that it plans to release its financial results for the fourth...

Extendicare Announces January 2024 Dividend of C$0.04 per Share

MARKHAM, Ontario, Jan. 15, 2024 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has declared a cash dividend of C$0.04 per common share of the...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1007.547.67.4592317.48570881CS
40.283.856749311297.268.037.221700317.66511447CS
12-0.28-3.580562659857.828.037.21344707.52037058CS
260.273.713892709777.278.036.631281997.35182882CS
520.141.891891891897.48.035.751302996.9926587CS
156-0.7-8.495145631078.248.715.751597157.1575887CS
260-0.8-9.592326139098.349.64.92163936.89268558CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
KAVLKaival Brands Innovations Group Inc
$ 5.96
(338.24%)
70.99M
LRHCLa Rosa Holdings Corporation
$ 1.165
(90.61%)
40.6M
SVMHSRIVARU Holding Ltd
$ 0.227586
(49.24%)
276.03M
BRFHBarfresh Food Group Inc
$ 3.03
(38.36%)
247.31k
NNENano Nuclear Energy Inc
$ 9.37
(32.53%)
1.77M
NXLNexalin Technologies Inc
$ 0.89
(-35.52%)
3.93M
INABIN8bio Inc
$ 1.095
(-34.82%)
4.92M
QXOQXO Inc
$ 134.10
(-34.71%)
142.29k
GANXGain Therapeutics Inc
$ 1.24
(-34.39%)
3.09M
KYTXKyverna Therapeutics Inc
$ 9.52
(-34.07%)
4.31M
NVDANVIDIA Corporation
$ 131.88
(1.75%)
309.34M
SVMHSRIVARU Holding Ltd
$ 0.227586
(49.24%)
276.03M
KITTNauticus Robotics Inc
$ 0.1921
(19.69%)
165.83M
CRKNCrown Electrokinetics Corporation
$ 0.0582
(-21.35%)
136.77M
SQQQProShares UltraPro Short QQQ
$ 8.43
(-1.29%)
112.46M

EXE Discussion

View Posts
MisterEC MisterEC 8 years ago
I have traded this a number of times. Back in at 5.90 this morning. Below is a statement from the Motley Fool analyst I heard about this stock from. Unfortunate I lost track of his coverage and all my trades were done after this was released, and before I read this, except when I got back in today.

Extendicare (NASDAQOTH:EXETF) -- This was a truly unfortunate experience, as management just worked over
shareholders in a terrible way. It ran the REIT's American business into the ground and then sold it at a low point
(very much like buy high/sell low investors). The conference call announcing the deal was unbelievable, and you
could hear the anxiety in the CEO's voice as he delivered the news and parried questions from analysts. With only
a little cash going back to shareholders in the form of a stock buyback -- surely after some investors twisted
management's arm -- shareholders were right to dump the stock. It would be much more accretive to buy back stock
at these prices, but management wants to expand the business. That would be poor capital allocation.
James Royal
(TMFRoyal)
Jan 23, 2015 at 10:06AM
👍️0
clotter2 clotter2 9 years ago
Extendicare breaking resistance level. This should get good from here . LONG+
👍️0
clotter2 clotter2 9 years ago
I want to talk $EXETF $TROV.. Health-care, Biopharm, and retail...
👍️0
toddski toddski 9 years ago
Extendicare (TSE:EXE) had its price target upped by CIBC from C$7.50 to C$8.00 in a research note issued to investors on Friday. The firm currently has a sector perform rating on the stock.

http://www.mideasttime.com/extendicare-given-new-c8-00-price-target-at-cibc-exe/362393/
👍️0
toddski toddski 9 years ago
Extendicare announced 10% share buyback program:

http://finance.yahoo.com/news/extendicare-announces-intention-issue-normal-223000319.html
👍️0

Your Recent History

Delayed Upgrade Clock